Anog, Susan R.

HRN: 28-62-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CEFTAZIDIME 1GM (VIAL)
02/24/2026
03/03/2026
IVTT
1g
Q8H
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: